ARNA, VGHI & Today’s Extended Watchlist

Arena Pharmaceuticals, Inc. ARNA

We have been covering ARNA for quite some time, since we learned of the possibility of an FDA approval. Yesterday that became a reality, with everyone and their brother discussing ARNA’s FDA approval, including the talking heads on CNBC. Around midday, the stock was briefly halted, before the announcement was made:

“On June 27, Arena Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved BELVIQ as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in obese or overweight adult patients. BELVIQ is the first prescription weight-loss treatment approved by the FDA in 13 Years.”

Shortly following, the stock was reopened for trading, and trade it did! 90.2 million shares, over 4 times the 3mo. average, traded hands. ARNA rose to a high of 13.50. We first alerted ARNA on May 11th, after which time the stock was trading as low as 5.44. That would represent a gain of 148% to yesterday’s high of 13.50.

We feel that once the initial clamor subsides, and the volitility calms a bit, we should see a bit of a pullback, as is to be expected with most astronomical gainers. That being said, the long-term for this stock looks very promising indeed, so while the excitement should begin to die down, our interest in following ARNA moving forward will not.


VHGI Holdings, Inc. VHGI

Monday, we stated: “On Friday the stock saw abnormally high volume coupled with the 52-week low, prompting us to put VHGI back on our watchlist in anticipation of an eventual bounce.”

It seems we came to this observation just in nick of time. The stock was as low as .055 following this alert. Since then it has seen a high of .095, equating to a gain of 73%. Those that have been with us for awhile know we are not one hit wonders in most cases when we cover a stock.

We will continue to monitor VHGI as it recovers off of its bottom, and in reality, we would not be shocked to see it return to previous support and higher. When we first covered this play, it ran from .20 to .75, and thus huge gains do not seem out of the realm of possibility for VHGI.


Extended Watchlist: